Literature DB >> 28299511

Epidemiologic paradigms for progress in ovarian cancer research.

Shelley S Tworoger1, Jennifer Anne Doherty2.   

Abstract

Entities:  

Year:  2017        PMID： 28299511      PMCID： PMC5676465          DOI： 10.1007/s10552-017-0877-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN： 0957-5243            Impact factor:   2.506


× No keyword cloud information.
  19 in total

1.  Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

Authors:  Elke A Jarboe; Ann K Folkins; Ronny Drapkin; Tan A Ince; Elin S Agoston; Christopher P Crum
Journal:  Histopathology       Date:  2009-11       Impact factor: 5.087

2.  Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.

Authors:  John R van Nagell; Paul D DePriest; Frederick R Ueland; Christopher P DeSimone; Amy L Cooper; J Matt McDonald; Edward J Pavlik; Richard J Kryscio
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

3.  Mathematical models of ovarian cancer incidence.

Authors:  Bernard A Rosner; Graham A Colditz; Penny M Webb; Susan E Hankinson
Journal:  Epidemiology       Date:  2005-07       Impact factor: 4.822

Review 4.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

5.  A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Authors:  Claire S Zhu; Paul F Pinsky; Daniel W Cramer; David F Ransohoff; Patricia Hartge; Ruth M Pfeiffer; Nicole Urban; Gil Mor; Robert C Bast; Lee E Moore; Anna E Lokshin; Martin W McIntosh; Steven J Skates; Allison Vitonis; Zhen Zhang; David C Ward; James T Symanowski; Aleksey Lomakin; Eric T Fung; Patrick M Sluss; Nathalie Scholler; Karen H Lu; Adele M Marrangoni; Christos Patriotis; Sudhir Srivastava; Saundra S Buys; Christine D Berg
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

Review 6.  Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.

Authors:  Leo J Schouten; Christine Rivera; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Alan Arslan; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Susan E Hankinson; James V Lacey; Michael Leitzmann; Annekatrin Lukanova; James R Marshall; Anthony B Miller; Alpa V Patel; Carmen Rodriguez; Thomas E Rohan; Julie A Ross; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

7.  A randomized study of screening for ovarian cancer: a multicenter study in Japan.

Authors:  H Kobayashi; Y Yamada; T Sado; M Sakata; S Yoshida; R Kawaguchi; S Kanayama; H Shigetomi; S Haruta; Y Tsuji; S Ueda; T Kitanaka
Journal:  Int J Gynecol Cancer       Date:  2007-07-21       Impact factor: 3.437

8.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

9.  An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.

Authors:  K Li; A Hüsing; R T Fortner; A Tjønneland; L Hansen; L Dossus; J Chang-Claude; M Bergmann; A Steffen; C Bamia; D Trichopoulos; A Trichopoulou; D Palli; A Mattiello; C Agnoli; R Tumino; N C Onland-Moret; P H Peeters; H B Bueno-de-Mesquita; I T Gram; E Weiderpass; E Sánchez-Cantalejo; M-D Chirlaque; E J Duell; E Ardanaz; A Idahl; E Lundin; K-T Khaw; R C Travis; M A Merritt; M J Gunter; E Riboli; P Ferrari; K Terry; D Cramer; R Kaaks
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

10.  Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Authors:  Ruth M Pfeiffer; Yikyung Park; Aimée R Kreimer; James V Lacey; David Pee; Robert T Greenlee; Saundra S Buys; Albert Hollenbeck; Bernard Rosner; Mitchell H Gail; Patricia Hartge
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069
View more
  3 in total

Review 1.  Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.

Authors:  Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

2.  A random forest classifier predicts recurrence risk in patients with ovarian cancer.

Authors:  Li Cheng; Lin Li; Liling Wang; Xiaofang Li; Hui Xing; Jinting Zhou
Journal:  Mol Med Rep       Date:  2018-07-19       Impact factor: 2.952

3.  Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.

Authors:  James Yarmolinsky; Caroline L Relton; Artitaya Lophatananon; Kenneth Muir; Usha Menon; Aleksandra Gentry-Maharaj; Axel Walther; Jie Zheng; Peter Fasching; Wei Zheng; Woo Yin Ling; Sue K Park; Byoung-Gie Kim; Ji-Yeob Choi; Boyoung Park; George Davey Smith; Richard M Martin; Sarah J Lewis
Journal:  PLoS Med       Date:  2019-08-07       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.